Molecules 2012, 17(6), 7595-7611; doi:10.3390/molecules17067595
Article

Down Regulation of CIAPIN1 Reverses Multidrug Resistance in Human Breast Cancer Cells by Inhibiting MDR1

Dan Lu 1,†,* email, Zhibo Xiao 2,† , Wenxiu Wang 1 , Yuqing Xu 1 , Shujian Gao 1 , Lili Deng 1 , Wen He 1 , Yu Yang 1 , Xiaofei Guo 1  and Xuemei Wang 1
1 Department of Oncology, the Second Affiliated Hospital of Harbin Medical University, Harbin 150086, China 2 Department of Plastic Surgery, the Second Affiliated Hospital of Harbin Medical University, Harbin 150086, China † These authors contributed equally to this work.
* Author to whom correspondence should be addressed.
Received: 13 March 2012; in revised form: 11 June 2012 / Accepted: 11 June 2012 / Published: 20 June 2012
PDF Full-text Download PDF Full-Text [1460 KB, uploaded 20 June 2012 14:37 CEST]
Abstract: Cytokine-induced apoptosis inhibitor 1 (CIAPIN1), initially named anamorsin, a newly indentified antiapoptotic molecule is a downstream effector of the receptor tyrosine kinase-Ras signaling pathway. Current study has revealed that CIAPIN1 may have wide and important functions, especially due to its close correlations with malignant tumors. However whether or not it is involved in the multi-drug resistance (MDR) process of breast cancer has not been elucidated. To explore the effect of CIAPIN1 on MDR, we examined the expression of P-gp and CIAPIN1 by immunohistochemistry and found there was positive correlation between them. Then we successfully interfered with RNA translation by the infection of siRNA of CIAPIN1 into MCF7/ADM breast cancer cell lines through a lentivirus, and the expression of the target gene was significantly inhibited. After RNAi the drug resistance was reduced significantly and the expression of MDR1mRNA and P-gp in MCF7/ADM cell lines showed a significant decrease. Also the expression of P53 protein increased in a statistically significant way (p ≤ 0.01) after RNAi exposure. In addition, flow cytometry analysis reveals that cell cycle and anti-apoptotic enhancing capability of cells changed after RNAi treatment. These results suggested CIAPIN1 may participate in breast cancer MDR by regulating MDR1 and P53 expression, changing cell cycle and enhancing the anti-apoptotic capability of cells.
Keywords: breast cancer; multidrug resistance; CIAPIN1gene; MDR1gene; RNA interference

Article Statistics

Click here to load and display the download statistics.

Cite This Article

MDPI and ACS Style

Lu, D.; Xiao, Z.; Wang, W.; Xu, Y.; Gao, S.; Deng, L.; He, W.; Yang, Y.; Guo, X.; Wang, X. Down Regulation of CIAPIN1 Reverses Multidrug Resistance in Human Breast Cancer Cells by Inhibiting MDR1. Molecules 2012, 17, 7595-7611.

AMA Style

Lu D, Xiao Z, Wang W, Xu Y, Gao S, Deng L, He W, Yang Y, Guo X, Wang X. Down Regulation of CIAPIN1 Reverses Multidrug Resistance in Human Breast Cancer Cells by Inhibiting MDR1. Molecules. 2012; 17(6):7595-7611.

Chicago/Turabian Style

Lu, Dan; Xiao, Zhibo; Wang, Wenxiu; Xu, Yuqing; Gao, Shujian; Deng, Lili; He, Wen; Yang, Yu; Guo, Xiaofei; Wang, Xuemei. 2012. "Down Regulation of CIAPIN1 Reverses Multidrug Resistance in Human Breast Cancer Cells by Inhibiting MDR1." Molecules 17, no. 6: 7595-7611.

Molecules EISSN 1420-3049 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert